Literature DB >> 12471579

Prospective immunogenicity study of multiple intradermal injections of rabies vaccine in an effort to obtain an early immune response without the use of immunoglobulin.

Pakamatz Khawplod1, Henry Wilde, Saovaluk Tepsumethanon, Sukunya Limusanno, Tanpetch Tantawichien, Pranee Chomchey, Ampai Bungjongkasaena Na Ayuthaya, Yongyuth Wangroonsarb.   

Abstract

The present study sought to determine whether increasing and accelerating rabies vaccine administration would result in earlier protective levels of neutralizing antibody. Results indicated that the 8-site and double-dose Thai Red Cross intradermal regimens produced higher antibody titers by day 14 but not significantly higher titers by days 5 and 7. Administration of rabies immunoglobulin into and around bite wounds on the first day of rabies prophylaxis should remain the optimal postexposure treatment.

Mesh:

Substances:

Year:  2002        PMID: 12471579     DOI: 10.1086/344954

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  5 in total

1.  Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis: results of a randomized, open label, active-controlled trial in healthy adult volunteers in India.

Authors:  Mysore Kalappa Sudarshan; Doddabele Hanumanthaiah Ashwath Narayana; Shampur Narayan Madhusudana; Ramesh Holla; Belludi Yajaman Ashwin; Bilagumba Gangaboraiah; Haradanahalli S Ravish
Journal:  Hum Vaccin Immunother       Date:  2012-08-01       Impact factor: 3.452

2.  Toward Elimination of Dog-Mediated Human Rabies: Experiences from Implementing a Large-scale Demonstration Project in Southern Tanzania.

Authors:  Emmanuel Abraham Mpolya; Tiziana Lembo; Kennedy Lushasi; Rebecca Mancy; Eberhard M Mbunda; Selemani Makungu; Matthew Maziku; Lwitiko Sikana; Gurdeep Jaswant; Sunny Townsend; François-Xavier Meslin; Bernadette Abela-Ridder; Chanasa Ngeleja; Joel Changalucha; Zacharia Mtema; Maganga Sambo; Geofrey Mchau; Kristyna Rysava; Alphoncina Nanai; Rudovick Kazwala; Sarah Cleaveland; Katie Hampson
Journal:  Front Vet Sci       Date:  2017-03-06

3.  Shortening intradermal rabies post-exposure prophylaxis regimens to 1 week: Results from a phase III clinical trial in children, adolescents and adults.

Authors:  Phirangkul Kerdpanich; Pornthep Chanthavanich; Mari Rose De Los Reyes; Jodor Lim; Delia Yu; Ma Cecilia Ama; Zenaida Mojares; Daniela Casula; Ashwani Kumar Arora; Michele Pellegrini
Journal:  PLoS Negl Trop Dis       Date:  2018-06-06

4.  Descriptive assessment of rabies post-exposure prophylaxis procurement, distribution, monitoring, and reporting in four Asian countries: Bangladesh, Bhutan, Cambodia, and Sri Lanka, 2017-2018.

Authors:  Anyie J Li; Nandini Sreenivasan; Umme Ruman Siddiqi; Sanya Tahmina; Kinley Penjor; Ly Sovann; Amila Gunesekera; Jesse D Blanton; Lea Knopf; Terri B Hyde
Journal:  Vaccine       Date:  2018-10-09       Impact factor: 4.169

5.  A simplified 4-site economical intradermal post-exposure rabies vaccine regimen: a randomised controlled comparison with standard methods.

Authors:  Mary J Warrell; Anna Riddell; Ly-Mee Yu; Judith Phipps; Linda Diggle; Hervé Bourhy; Jonathan J Deeks; Anthony R Fooks; Laurent Audry; Sharon M Brookes; François-Xavier Meslin; Richard Moxon; Andrew J Pollard; David A Warrell
Journal:  PLoS Negl Trop Dis       Date:  2008-04-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.